University of Ioannina
Μελέτη ενδιαμέσων μιτωτικών σημάτων και αλλαγών στη γονιδιακή έκφραση με τη χρήση επαγόμενων κυτταρικών συστημάτων έκφρασης του ογκογονιδίου ras
Abstract
dc:descriptionCancer is a disease where the fundamental rules of cell behavior break down. The development of cancer could be due to abnormal expression or function of specific cellular genes like oncogenes (e.g.Ras). In this thesis we describe the Ras expression and we study the signaling events following H-Ras activation. The gene expression profile analysis of Ras using macroarrays is a second goal of this thesis that gives us the opportunity of examining the target genes that are related to initiation and/or maintenance of carcinogenesis. It is worth mentioning that the RAS mutations are restricted to a single RAS gene and are often tissue specific or dependent upon cancer type. Thus, Ras helped us to characterize downstream events and to identify signaling factors that regulate the expression of genes that are involved in cell death, cellular growth and transformation. To examine early signaling events following the Ha-RASV12 activation [a constitutively active mutated form of the protein with substitution of Gly to Val (12)] and the effect of expression towards cell proliferation, a constitutive expression system of Ras and an ecdysone inducible expression system were developed in HEK - 293 human epithelial kidney cells. The Ecdysone inducible system uses a heterodimer of the ecdysone receptor (VgEcR) and the retinoid X receprtor (RXR) that binds 5 modified ecdysone response elements in the presence of a steroid hormone, ponasterone A, to activate expression of the transfected gene. Thus, to examine early Ras signaling events towards cell proliferation and cell death, the ecdysone inducible expression system of Ha-RASV12 was used (293indRas cells). This inducible expression system of oncogenic Ras under low serum conditions 180 induced biological functions such as growth arrest, cellular senescence and apoptosis. Moreover, the inducible expression of HaRASV12 under low serum conditions led to transient activation of MAPK. We also used a second system in which Ha-RASV12 oncoprotein (293conRas cells) is constitutively expressed under normal serum conditions and in which the transformation process is induced in a larger fraction than in 293indRas cells. In order to validate the cellular properties resulting from the oncogenic expression of HaRASV12 in transformed HEK-293 cells expressing Ras either in an inducible manner at an early stage (2 hours post induction with ponasterone) or intermediate stage (6 hours post induction with ponasterone) or in a constitutive manner (293conRas), gene expression profile analysis was performed by using a human oncoarray cDNA. In parallel, early genes that are regulated specifically after Ras induction and not after induction by serum were identified. Thus genes related to all cell functions were revealed. It was observed that target genes that are upregulated from Ras signaling can act independently or cooperate with each other to trigger early, intermediate and late Ras events. In conclusion, we refer to identification of early genes such as the proline oxidase (POX) gene that has not been previously been reported in Ras signaling. These genes could be further studied in the near future as potentially novel targets for therapy in Ras bearing tumors.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Moumtzi, Sofia
- Μουμτζή, Σοφία
Subjects
dc:subject × 20Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/17771